Hisense Ltd. was founded in 1991 and in 1992 developed the first-to-market non-touch breathing movement monitor for detection of apnea in infants, known under the trade mark - Babysense.
Since then, the company has gained a solid expertise in developing and producing quality breathing movement monitors, meeting the stringent requirements and needs of both the institutional and private market.
Hisense is active in detection and prevention of sudden infant death syndrome (SIDS) being the leading cause of death in infants under one year old with an average death toll reaching 5,600 babies per year in the USA and Europe alone.
Babysense breathing monitor is certified as a Class IIb Medical Device approved to the Medical Devices Directive (CE) 93/42/EEC.
Hisense has established solid relationships with maternity wards, gynecologists, pediatricians, clinics.
Our core product - Babysense breathing movement monitor - is used in hundreds of hospitals and have helped protecting over 600,000 infants from SIDS.
Hisense is present in 35 countries through its subsidiaries and exclusive international distributors.
Hisense is ISO 9001 and ISO 13485 (medical devices) certified.